➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Merck
Express Scripts
Colorcon
McKinsey

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Patent: 9,994,903

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,994,903
Title:Transcriptomic index for characterizing the cellular repair response after soft tissue injury in diarthrodial joints
Abstract: One aspect of the Invention provides methods for classifying the quality of a repair response after injury to a joint of a subject. In one embodiment, the method includes providing a tissue sample from the injured region of the joint and determining expression levels in the sample of a plurality of genes, including at least those genes listed in Table 1, Table 2 and Table 3, Another aspect of the Invention provides methods of treating a human or veterinary subject having an injury to a joint based on the classification of the quality of the repair response.
Inventor(s): Chan; Deva (Chicago, IL), Li; Jun (Chicago, IL), Plaas; Anna H. K. (Chicago, IL), Sandy; John D. (Chicago, IL), Wang; Vincent (Chicago, IL)
Assignee: RUSH UNIVERSITY MEDICAL CENTER (Chicago, IL)
Application Number:14/916,817
Patent Claims:see list of patent claims

Details for Patent 9,994,903

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial RUSH UNIVERSITY MEDICAL CENTER (Chicago, IL) 2033-09-12 RX search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 003 1978-01-16   Start Trial RUSH UNIVERSITY MEDICAL CENTER (Chicago, IL) 2033-09-12 DISCN search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 002 1978-01-16   Start Trial RUSH UNIVERSITY MEDICAL CENTER (Chicago, IL) 2033-09-12 DISCN search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 001 1978-01-16   Start Trial RUSH UNIVERSITY MEDICAL CENTER (Chicago, IL) 2033-09-12 DISCN search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
McKesson
AstraZeneca
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.